| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/05/2006 | US7101711 Activating a T gamma 9 delta 2 lymphocyte at a minimum activation concentration of below 100 nM, in vitro by contacting with a 3,4-epoxy-3-methyl-1-butyl diphosphate substituted with a biomolecule |
| 09/05/2006 | US7101704 Expressing a co-stimulatory molecule, treated with interferon- gamma, and modified to have an exogenous antigen fragment bound to MHCII; antigen is presented to initiate an immune response |
| 09/05/2006 | US7101562 Conjugate vaccines for the prevention of dental caries |
| 09/05/2006 | US7101560 Combination vaccine for administration to adolescents |
| 09/05/2006 | US7101559 Immunomodulatory protein and useful embodiments thereof |
| 09/05/2006 | US7101553 Administering prebiotic such as fructo-oligosaccharide; measles prevention; vaccines; nutrients |
| 09/05/2006 | US7101550 Agents for modulating PD-1, B7-4, and the interaction between B7-4 and PD-1 in order to modulate a costimulatory or an inhibitory signal in a immune cell resulting in modulation of the immune response |
| 09/05/2006 | US7101548 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology |
| 09/05/2006 | US7101539 Increasing hematopoietic progenitor cells in a mammal by adminstering an interleukin-like polypeptide |
| 09/05/2006 | CA2393640C Pyrrolo[2,3-d]pyrimidine compounds |
| 09/05/2006 | CA2143642C Immunoreactive peptides from epstein-barr virus |
| 09/05/2006 | CA2099707C Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins |
| 08/31/2006 | WO2006090932A1 Surrogate marker for sulfonamide compound |
| 08/31/2006 | WO2006090921A1 Inhibitory effect of sulfonamide compound on lymphocyte activation |
| 08/31/2006 | WO2006090874A1 Method of analyzing mammalian t cell cytokines, method of evaluating all of related diseases and analysis of prevention and therapy therefor |
| 08/31/2006 | WO2006090853A1 Nitrogenous heterocyclic compound and medicinal use thereof |
| 08/31/2006 | WO2006090817A1 Indole compound and use thereof |
| 08/31/2006 | WO2006090729A1 Fermented tea beverage and tea beverage |
| 08/31/2006 | WO2006090698A1 Kinase inhibitor and use thereof |
| 08/31/2006 | WO2006090150A1 Pharmaceutical composition comprising amorphous rosiglitazone |
| 08/31/2006 | WO2006090143A1 4-0x0quinaz0lin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 08/31/2006 | WO2006089980A1 Nucleic acids and allergens of olive tree pollen of defined olive tree varieties and applications thereof |
| 08/31/2006 | WO2006089690A1 Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents |
| 08/31/2006 | WO2006089549A1 Ykl-40 monoclonal antibodies |
| 08/31/2006 | WO2006072599A3 Androstane 17-alpha carbonate derivatives for use in the treatment of allergic and inflammatory conditions |
| 08/31/2006 | WO2006064121A3 Cytotoxic antibody directed against type b lymphoid hematopoietic proliferations |
| 08/31/2006 | WO2006048862A3 The use of a protease or a protease inhibitor for the manufacture of medicaments |
| 08/31/2006 | WO2006028956A3 Anti-fc-gamma riib receptor antibody and uses therefor |
| 08/31/2006 | WO2005120577A3 Derivatives of chemotherapeutic agents with a formaldehyde releasing moeity |
| 08/31/2006 | US20060194881 Composition comprising at least one alkanolamide to inhibit megration of langerhans cells and uses therof |
| 08/31/2006 | US20060194864 Indole derivatives |
| 08/31/2006 | US20060194863 e.g. [(4-Morpholinophenylamino)-methylene]-1,3-dihydro-indol-2-one;tyrosine kinase signal transduction modulators; antiproliferative agents; vision defects, atherosclerosis, restenosis, metabolic disorders, autoimmune diseases |
| 08/31/2006 | US20060194851 Benzofuran compound and medicinal composition containing the same |
| 08/31/2006 | US20060194848 Substituted amine derivatives and methods of use |
| 08/31/2006 | US20060194843 4-(2,6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide; anticancer agents; carcinoma of the colon; antifungal agents; antitumor agents; infections; 4-(2,6-difluoro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methyl-piperidin-4-yl)-amide |
| 08/31/2006 | US20060194822 Treatment for renal fibrosis |
| 08/31/2006 | US20060194818 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194811 Pyrimidine derivatives |
| 08/31/2006 | US20060194793 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194792 1-Cyclic carbonyl-4-(4-quinoline-)-1,4-diazepine or 1-cyclic carbonyl-4-[4-(1H-quinolin-2-{thio}one)-1,4-diazepinone derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 08/31/2006 | US20060194755 Compositions and methods for regulating an immune response in a subject |
| 08/31/2006 | US20060194745 Compounds and methods for inhibiting selectin-mediated function |
| 08/31/2006 | US20060194291 Comprising human immunoglobulin g1 fc region, which mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity |
| 08/31/2006 | US20060194290 Polypeptide variants with altered effector function |
| 08/31/2006 | US20060193855 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 08/31/2006 | US20060193852 immunotherapy, preferably against B-cell malignancies such as non-Hodgkin lymphoma; single-chain multifunctional polypeptides comprising at least two binding sites specific for the CD19 and CD3 antigen; domains are arranged in the order VLCD19-VHCD19-VHCD3-VLCD3; vector; cell |
| 08/31/2006 | US20060193826 Methods to mobilize progenitor/stem cells |
| 08/31/2006 | CA2599439A1 Ykl-40 monoclonal antibody |
| 08/31/2006 | CA2599348A1 Indole compound and use thereof |
| 08/31/2006 | CA2598961A1 Nutritional composition with probiotics |
| 08/31/2006 | CA2598943A1 4-0x0quinaz0lin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 08/31/2006 | CA2596794A1 Tea-based fermentation beverage and tea beverage |
| 08/31/2006 | CA2593532A1 Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents |
| 08/30/2006 | EP1696033A2 Pseudomonas exotoxin A-like chimeric immunogens |
| 08/30/2006 | EP1695974A1 1,8-Naphthyridines as CRF antagonists |
| 08/30/2006 | EP1695970A1 Peptides useful for competitive modulation of dipeptidyl peptidase IV catalysis |
| 08/30/2006 | EP1694839A2 Laminin-5 modulators and uses thereof |
| 08/30/2006 | EP1694706A2 Modified anti-cd52 antibody |
| 08/30/2006 | EP1694358A2 Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases |
| 08/30/2006 | EP1694357A1 Use of cathepsin s inhibitors for treating an immune response caused by administration of a small molecule therapeutic or biologic |
| 08/30/2006 | EP1694331A1 Methods for suppressing an immune response or a treating a proliferative disorder |
| 08/30/2006 | EP1694320A1 Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity |
| 08/30/2006 | EP1513837B1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 08/30/2006 | EP1482811B1 Process for the preparation of foods comprising a probiotic delivery system |
| 08/30/2006 | EP1479773B1 Mite galectin |
| 08/30/2006 | EP1436292B1 5-methoxy-8-aryl-¬1,2,4|triazolo¬1,5-a|pyridine derivatives as adenosine receptor antagonists |
| 08/30/2006 | EP1425280B1 Hetero-bicyclic crf antagonists |
| 08/30/2006 | EP1414810B1 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 08/30/2006 | EP1385519B1 Compounds for treating inflammatory diseases |
| 08/30/2006 | EP1334188B1 Cd19-specific redirected immune cells |
| 08/30/2006 | EP1318811B1 Cyclopentyl modulators of chemokine receptor activity |
| 08/30/2006 | EP1297011B1 Diagnostic uses of the t-cell protein tzon7, and of the peptides and antibodies derived therefrom |
| 08/30/2006 | EP1266008B1 Acute neuronal induced calcium binding protein type 1 ligand |
| 08/30/2006 | EP1255724B1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 08/30/2006 | EP1210430B1 Muc-1 derived peptides |
| 08/30/2006 | EP1202953B1 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 08/30/2006 | EP1171604B1 Dna sequence and recombinant production of a graminae allergen |
| 08/30/2006 | EP0728200B1 Haemophilus transferrin receptor genes |
| 08/30/2006 | EP0529033B1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof |
| 08/30/2006 | CN1826339A 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof |
| 08/30/2006 | CN1826336A Cyclohexanecarboxylic acid compound |
| 08/30/2006 | CN1826323A 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 08/30/2006 | CN1826111A Imidazole derivatives for treatment of allergic and hyperproliferative disorders |
| 08/30/2006 | CN1824656A Methods and compositions utilizing quinazolinones |
| 08/30/2006 | CN1824327A Preparation method of nucleic acid vaccine guided by using chicken MHC constant chain gene segment |
| 08/30/2006 | CN1824306A Immunoglobulin-G biofactor chewing gum |
| 08/30/2006 | CN1824291A Hypersensitivity reaction inhibitor |
| 08/30/2006 | CN1824152A Medicine and food dual purpose Chinese Medicinal nutritive product for preventing and treating bacchia and its manufacturing method |
| 08/30/2006 | CN1824120A Oral liquid capable of raising human body anoxia tolerance and its preparation method |
| 08/30/2006 | CN1824031A Medicinal tea for treating apopsychia |
| 08/30/2006 | CN1824028A Formula of Chinese medicine health protection wine |
| 08/30/2006 | CN1823983A Medicine for treatign osteopathia, rheumatism and immune disease and its preparation method and use |
| 08/30/2006 | CN1823870A Celastrus orbiculatus ready prepared Chinese medicine and its application in resisting rheumatoid disease |
| 08/30/2006 | CN1823855A Preparation method of yellow gumbo freeze dried powder |
| 08/30/2006 | CN1823849A Extract of ferric trichloride and algae |
| 08/30/2006 | CN1823848A Potent immunostimulants from microalgae |
| 08/30/2006 | CN1823780A Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 08/30/2006 | CN1823771A FK506 oral medicinal composition |
| 08/30/2006 | CN1823758A Compounds and methods of treating transplant rejection |
| 08/30/2006 | CN1823607A Chinese medicinal herb feed additive used for aquaculture and its use method |